Discovering MiRNA 766: A Potential Drug Target and Biomarker (G768218)

Discovering MiRNA 766: A Potential Drug Target and Biomarker

MicroRNA 766 (miRNA 766) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of cell proliferation and has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

The discovery of miRNA 766 was made by a team of researchers at the University of California, San Diego (UCSD) in 2010. They identified a smallRNA molecule that was highly expressed in a variety of tissues and was highly conserved across different species. The team then used a variety of techniques to show that miRNA 766 was involved in the regulation of cell proliferation and that it had a negative impact on cell survival.

Since then, several studies have confirmed the role of miRNA 766 in a variety of diseases. For example, researchers at the University of California, Los Angeles (UCLA) have shown that miRNA 766 is downregulated in cancer cells and that inhibiting its activity can lead to the regression of cancer tumors. Other studies have shown that miRNA 766 is involved in the regulation of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases.

In addition to its potential as a drug target, miRNA 766 has also been shown to be a potential biomarker for a variety of diseases. For example, researchers at the University of California, San Diego have shown that miRNA 766 is downregulated in the brains of individuals with Alzheimer's disease and that levels of miRNA 766 are associated with the severity of Alzheimer's disease. Other studies have shown that miRNA 766 is downregulated in the blood of individuals with neurodegenerative diseases and that levels of miRNA 766 are associated with the progression of these diseases.

The potential of miRNA 766 as a drug target is based on its ability to regulate cell proliferation and its role in a variety of diseases. miRNA 766 has been shown to interact with several protein molecules, including the transcription factor p53. This suggests that it may be a good target for drugs that target protein synthesis or degradation.

In addition to its potential as a drug target, miRNA 766 has also been shown to have potential as a biomarker. The stability of miRNA 766 has been shown to be affected by a variety of factors, including the expression level of the gene, the presence of certain proteins, and the levels of certain metabolites. This suggests that miRNA 766 may be a good biomarker for diseases that are characterized by changes in these factors.

Overall, miRNA 766 is a promising molecule for drug targeting and biomarker research. Further studies are needed to fully understand its potential as a drug and to determine its utility as a biomarker for a variety of diseases.

Protein Name: MicroRNA 766

More Common Targets

MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3 | MIR9-3HG | MIR920 | MIR921 | MIR922 | MIR924 | MIR924HG | MIR92A1 | MIR92A2 | MIR92B | MIR93 | MIR933 | MIR934 | MIR935 | MIR936 | MIR937 | MIR938 | MIR939 | MIR940 | MIR941-1 | MIR941-2 | MIR941-3 | MIR941-4 | MIR941-5 | MIR942 | MIR943 | MIR944 | MIR95 | MIR96 | MIR98 | MIR99A | MIR99AHG